Urolithin A na jan hankalin kowa, tare da gwaje‑gwajen klinik da abubuwan da ke kan kasuwa. Amma wani sabon takarda ya haskaka ɗan'uwansa da ba a san shi sosai ba, Urolithin D, a cikin bincike. A cikin berayen da suka tsufa, an samu alamar ingantaccen tunawa, ƙasa da lalacewar hippocampus, da ƙara aikin tsabtace mitochondria na sel.
Lura: Wannan bincike ya ƙunshi dabbobi da gwaje‑gwajen sel ne kawai. Babu bayanan mutane, kuma Urolithin D ba shi da samfurin kari da ake sayarwa a kasuwa.
Binciken a Taƙaice
An wallafa aikin a matsayin Chen P, Wang Y, Huang Y, et al., "Ellagitannin Metabolite Urolithin D Ameliorates Cognitive Function and Behavioral Performance in Aging Mice Partially via AMPK/PGC-1α/SIRT3-Dependent Regulation of Mitophagy-Related Molecular Machinery," Molecular Neurobiology, 2026;63(1):952. DOI: 10.1007/s12035-026-06245-5. PubMed: 42842065.
Kungiyar da ke Wuhan, China, ta gwada Urolithin D a cikin yanayi guda biyu:
- Beraye: Dabbobi sun sha allurar intraperitoneal ta 150 mg/kg na D‑galactose na tsawon makonni 8. Har ila yau, an ba su Urolithin D ta baki a 50–150 mg/kg a kowace rana.
- Sel: Sel‑sel na neuronal HT22 (layin sel na hippocampus) an ƙara musu D‑galactose don duba tasirin Urolithin D a kan mitochondria da hanyoyin da suka shafi ƙwayoyin.
Me Ya Sa Samfurin Ya Muhimmanci
"Tsufan" a cikin waɗannan berayen ba na halitta ba ne. Ana allurar D‑galactose da ƙima mai yawa don haifar da tsufar sinadarai, wata hanya da ake yawan amfani da ita a dakin gwaje‑gwaje. Wannan hanya tana taimakawa wajen tantance ƙwayoyi, amma ba ta wakiltar tsufar da beraye (ko mutane) ke fuskanta a zahiri. Kowace ƙoƙari na "mayar da tsufa baya" zai kasance mai tsanani.
Abin Da Urolithin D Ya Yi
A cewar takaitaccen sakamakon, maganin Urolithin D a cikin berayen D‑galactose ya:
- Inganta aikin kwakwalwa da halayen tunawa
- Rage lalacewar hippocampus (wurin da ke da alhakin tunawa)
- Kula da plastisiti na synaptic
- Rage alamu na tsufa
Takaitaccen bayani bai ba da ƙididdiga ba, don haka "inganta" na nufin abin da marubutan suka rubuta a matsayin sakamako mai kyau, ba ma’anar dawowar cikakken tunawa ba.
Hanyar Aiki: Tsabtace Mitochondria
Marubutan sun danganta tasirin ga mitophagy, tsarin da sel ke amfani da shi don kawar da mitochondria masu lahani. Sun nuna cewa Urolithin D:
- Ya ƙara matakan AMPK, PGC‑1α da SIRT3 na mitochondria, waɗanda ke kula da makamashi da aikin mitochondria
- Ya sauya siginar da ke da alaka da mitophagy, tare da canjin bayyana Beclin1, LC3, P62, Parkin da PINK1
- A cikin sel‑sel na neuronal da aka ƙara musu stress, ya taimaka daidaita siffar mitochondria, rage oxidative stress da daidaita calcium
Gwaje‑gwajen sel sun tantance dalilin tasirin. Rage SIRT3 a cikin sel HT22 ya ƙara lalacewar mitochondria kuma ya rage aikin mitophagy. Hana AMPK ko PGC‑1α ya kawar da kariyar Urolithin D, yayin da ƙara SIRT3 ya rage matsalolin da D‑galactose ya haifar.
Marubutan sun ce Urolithin D "cikin wani ɓangare" yana haifar da canje‑canje da suka dace da farfadowar mitophagy ta hanyar hanyar AMPK/PGC‑1α/SIRT3. "Cikin wani ɓangare" na nuni da cewa wannan hanya ɗaya ce daga cikin hanyoyi da yawa da ka iya taka rawa.
Urolithin D da Urolithin A: Abin Da Za Mu Iya Faɗi da Abin Da Ba Za Mu Iya Faɗi Ba
Takardar ba ta kwatanta Urolithin D da Urolithin A ba. Ba a nuna cewa D ya fi A, ya yi daidai da A, ko ya yi aiki ta wata hanya daban ba. An bayyana kawai cewa duka biyun suna cikin iyalin metabolites da aka samo daga hanji, kuma Urolithin A, wadda aka fi sani, tana da kayayyakin kari a kasuwa, yayin da Urolithin D ke nan a cikin takardun bincike kawai.
Abin da sabon aikin ya ƙara shine alamar cewa wasu urolithins na iya shafar axis na mitophagy‑AMPK‑SIRT3 a cikin sel‑sel na kwakwalwa.
Daga Ina Urolithins Suke Fitowa
Urolithins ba su cikin abinci kai tsaye. Ellagitannins da ellagic acid, da ake samu a 'yan itacen ruwan inabi da gwanda (da kuma wasu berries), suna canzawa ta kwayoyin hanji zuwa urolithins. Wannan yana da ma’anoni biyu:
- Mutane na bambanta a wane urolithin hanjinsu ke samarwa, da kuma yawan da ake samu.
- Cin abincin da ke da ellagitannin ba ya nufin shan sinadarin tsarkakakke a matakan da aka yi amfani da su a beraye.
Abubuwan Da Za A Iya Yi A Aiki
Kima: Babu ƙima ga mutane na Urolithin D. 50–150 mg/kg/ran a beraye wani ƙima ne na dakin gwaje‑gwaje kuma ba za a iya juya shi zuwa adadin da ya dace ko amintacce ga mutum ba.
Lokaci: Berayen an ba su magani kullum na tsawon makonni 8 tare da D‑galactose. Wannan tsari ne na rigakafi, ba shaida ba ce game da magance matsalolin tunawa da suka riga sun faru, kuma ba ya nuna mafi kyawun lokacin shan maganin.
Waɗanda zai iya amfana: A halin yanzu, masu bincike ne mafi yawan amfana. Ga masu karatu na yau da kullum, matakin da ya dace shine cin abincin da ke da ellagitannin kamar ruwan inabi da gwanda, ko kuma dubawa ga kayayyakin Urolithin A da ke kasuwa. Ku duba hujjoji da ingancin kowanne samfur da kanku.
Waɗanda ya kamata su guje shi: Kowa da ke fatan magance asarar tunawa ko cutar kwakwalwa da kansa ta wannan sinadari. Hakanan a yi taka‑tsan‑tsan ga masu ciki, masu shan magunguna, ko masu wata cuta; a tattauna da likita kafin a sha ƙari na sinadari. Ba a tantance amincin Urolithin D a mutane ba a wannan aikin.
Abubuwan Da Za A Sa Ido
- Gwaje‑gwajen mutane: Babu wani a cikin wannan takarda. Nemo bayanan pharmacokinetic da amincin da farko.
- Gwaje‑gwajen kai tsaye: Kwatanta da Urolithin A zai nuna ko D na da wani abu daban.
- Samfuran tsufa na halitta: Sakamakon da aka samu a cikin tsufa da aka haifar da sinadari ya kamata a tabbatar da su a cikin dabbobin da suka tsufa da kansu.
- Kashin kwakwalwa: Binciken bai nuna adadin Urolithin D da ke shiga kwakwalwar mutum bayan shan baki ba.
Karshe
Urolithin D wani jagora ne mai ban sha'awa a matakin farko: a cikin berayen da aka haifar da D‑galactose da sel‑sel na neuronal, ya inganta sakamakon da suka shafi tunawa ta hanyar hanyar AMPK, PGC‑1α, SIRT3 da mitophagy. Ba a tabbatar da shi a matsayin maganin tunawa na mutane ba, kuma ba shi da samfurin kari da za a iya kimanta shi a yanzu. Marubutan sun bayyana babu wata sha'awar kasuwanci, kuma an samu amincewar hukumar kiwon lafiya ta dabbobi.